COPAXONE® (glatiramer acetate injection) is used to treat relapsing forms of multiple sclerosis (MS). It is a subcutaneous injection made with a nonpyrogenic solution, 20 mg or 40 mg of glatiramer acetate, and 40 mg of the inactive ingredient mannitol.1
COPAXONE® (glatiramer acetate injection) Current Prescribing Information Parsippany, NJ. Teva Neuroscience, Inc.
Injections for 3-times-a-week COPAXONE® 40 mg must be at least 48 hours apart.
Apple is a registered trademark of Apple Inc. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC.
You are about to leave this site
You are about to leave COPAXONE.com and enter a website operated by a third party.
Would you like to continue?
Are you a healthcare professional?
The information on this site is intended for healthcare professionals in the United States. Are you a healthcare professional in the United States?